Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics. Its technology platform creates and screens diverse antibody repertoires and...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of OmniAb (NASDAQ:OABI) through any online brokerage.
Other companies in OmniAb’s space includes: Thermo Fisher Scientific Inc (NYSE:TMO), Danaher Corp (NYSE:DHR), Agilent Technologies Inc (NYSE:A), IQVIA Holdings Inc (NYSE:IQV) and Waters Corp (NYSE:WAT).
OmniAb has a consensus price target of $8.00.
The stock price for OmniAb (NASDAQ: OABI) is $4.96 last updated October 21, 2026 at 9:28 AM EDT.
There are no upcoming dividends for OmniAb.
OmniAb does not have any upcoming earnings scheduled.
There is no upcoming split for OmniAb.
OmniAb is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.